Shandong Wohua Pharmaceutical Co., Ltd. logo

Shandong Wohua Pharmaceutical Co., Ltd. (002107)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
5. 30
+0.1
+1.92%
¥
3.07B Market Cap
40.47 P/E Ratio
0.25% Div Yield
5,421,980 Volume
0 Eps
¥ 5.2
Previous Close
Day Range
5.22 5.34
Year Range
3.2 6.64
Want to track 002107 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002107 Chart

Shandong Wohua Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Ms. Yingzi Zeng CEO
XSHE Exchange
CNE000001QB8 ISIN
CN Country
1,353 Employees
- Last Dividend
29 May 2020 Last Split
24 Jan 2007 IPO Date

Overview

Founded in 2003 and headquartered in Weifang, China, Shandong Wohua Pharmaceutical Co., Ltd. is a leading provider of pharmaceutical products within the Chinese healthcare sector. Operating as a key subsidiary of Beijing Zhongzheng Wanrong Investment Group Co., Ltd., Wohua Pharmaceutical has established itself as a stalwart in the research, development, manufacture, and sale of a wide range of pharmaceutical formulations and medical solutions. The company's comprehensive portfolio includes tablets, capsules, granules, powders, and various types of pills, alongside oral liquids and other medicinal forms. In addition to its extensive product range, Wohua Pharmaceutical offers specialized medical technology consulting services, further contributing to its status as a comprehensive healthcare provider. With a strong commitment to addressing cardiovascular and cerebrovascular diseases, musculoskeletal disorders, urinary system diseases, pediatric illnesses, skin diseases, and more, Wohua continues to innovate and expand its offerings to meet the evolving needs of patients across different therapeutic areas.

Products and Services

Shandong Wohua Pharmaceutical Co., Ltd.'s rich product portfolio caters to a wide array of health conditions, leveraging advanced pharmaceutical technologies and practices. Here is a closer look at some of their key products and services:

  • Cardiovascular and Cerebrovascular Products: These include Wohua Xinkeshu tablets and Holdan tablets and capsules, designed for heart and blood vessel health. Naoxueshu and Shenzhiling oral liquid, alongside Tongluo Huatan capsules, are aimed at improving circulation and supporting brain health.
  • Musculoskeletal Products: For bone and joint health, Wohua offers Gushukang capsules/granules and Yuandu Hanbi liquid. Kite cold paralysis medicine liquor is tailored for the relief of conditions like cold-induced paralysis.
  • Urinary System Products: Amber hydrazine particles are developed specifically for the treatment of diseases affecting the urinary system, providing patients with specialized care.
  • Pediatric Products: Recognizing the unique medical needs of children, Wohua produces Pediatric Antipyretic granules to address fever and common ailments in pediatric medicine.
  • Dermatological Products: Anti-ginseng anti-itch particles offer relief from various skin diseases, reflecting Wohua's dedication to comprehensive care solutions.
  • Products for Digestive and Gynecological Diseases: Echinacea capsules are part of Wohua’s offering for digestive health, while products like Siyu Yangxue Yishen granules attend to gynecological conditions, showcasing the company's focus on women’s health.
  • Medical Technology Consulting Services: Beyond pharmaceuticals, Wohua Pharmaceutical provides expert consulting services in medical technology, aiding healthcare professionals and organizations in navigating the complex landscape of medical treatments and innovations.

Contact Information

Address: No. 3517 Liyuan Street, Weifang, China, 261205
Phone: 86 53 6855 3373